Fig. 3From: Cost containment by peer prior authorization program for second line treatment in patients with retinal diseaseMonthly requests submission rate (source: authors’ analysis of data from Clalit Mushlams’ cohort of members funding applications, March 1, 2012 to December 31, 2015)Back to article page